Sastasundar Ventures Ltd

Health X Platform Ltd has announced that its Board of Directors will convene on November 14, 2026. The primary agenda item is to consider and approve the Unaudited Standalone and Consolidated Financial Results for the quarter and half-year ended September 30, 2026. Additionally, the company confirmed that the trading window for its securities will remain closed until 48 hours after the declaration of these financial results.

Health X Platform Ltd announced that all seven agenda items presented at its 37th Annual General Meeting (AGM) on September 28, 2026, were approved by the shareholders with the requisite majority. The resolutions included the adoption of audited financial statements for the fiscal year ending March 31, 2026, and the re-appointment of a director. The voting results, compiled through remote e-voting and poll, indicated strong support for all proposed agenda items. The company has made these results available on its website and that of its Registrar and Share Transfer Agent.

Health X Platform Ltd has announced the closure of its trading window for all designated persons and their immediate relatives. This closure is in accordance with SEBI (Prohibition of Insider Trading) Regulations, 2015, and the company's internal code of conduct. The trading window will be shut from October 1st, 2026, until 48 hours after the declaration of the company's un-audited financial results for the quarter and half-year ended September 30th, 2026. The specific date for the board meeting to consider these results will be communicated separately.

Health X Platform Ltd (formerly Sastasundar Ventures Limited) has issued a disclosure regarding its 37th Annual General Meeting (AGM) scheduled for September 28, 2026, to be held via Video Conferencing. The company is providing a web-link for members who have not registered their email addresses to access the complete Annual Report for FY 2025-26 and the Notice of AGM. Additionally, the filing serves as an intimation to holders of physical securities to furnish KYC and Nomination details to the RTA, MUFG Intime India Private Limited, as per SEBI regulations. This includes updating PAN, address, bank details, and specimen signatures, with implications for dividend payments if not updated by April 1, 2024.

Health X Platform Ltd has submitted its Business Responsibility and Sustainability Report (BRSR) for the Financial Year 2025-26, as per SEBI regulations. The report details the company's corporate identity, operations, employee data, and business activities, which are primarily wholesale trading of pharmaceutical and OTC products, accounting for 98.80% of turnover. The company operates on a consolidated basis and serves the national market. Key contact for BRSR queries is Mr. Banwari Lal Mittal, Chairman & Managing Director. The report is also available on the company's website.

Health X Platform Ltd has filed its Annual Report for the Financial Year 2025-26, as per SEBI regulations. The report includes statutory reports, consolidated and standalone financial statements, directors' report, and management discussion and analysis. Key financial highlights for FY 2025-26 show a standalone net loss of ₹95.12 Lakhs and a consolidated net loss of ₹144.73 Lakhs. The company also reported a consolidated total comprehensive income of ₹73.68 Lakhs for the period. The report is available on the company's website and will be sent electronically to members.

Health X Platform Ltd has announced its 37th Annual General Meeting (AGM) will be held on Monday, September 28, 2026, at 3:00 PM IST. The meeting will be conducted via Video Conferencing (VC) or Other Audio Visual Means (OAVM). Key agenda items include the adoption of audited financial statements for the fiscal year ended March 31, 2026, the re-appointment of a director retiring by rotation, and the re-appointment of Mrs. Anjana Dikshit as an Independent Director for a second five-year term. Additionally, the company seeks approval for its overall borrowing limit under Section 180(1)(c) of the Companies Act, 2013. The notice is being sent electronically to members with registered email addresses and is also available on the company's website.

Health X Platform Limited (formerly Sastasundar Ventures Limited) has announced its 37th Annual General Meeting (AGM) will be held on Monday, September 28, 2026, at 3:00 PM IST. The meeting will be conducted via Video Conferencing (VC) or Other Audio Visual Means (OAVM), in compliance with circulars from the Ministry of Corporate Affairs and SEBI. The notice of the AGM, along with the annual report for the financial year ended March 31, 2026, will be submitted in due course. The intimation is also available on the company's website.

Health X Platform Ltd announced that its Board of Directors, in a meeting held on August 7, 2026, approved the unaudited financial results (standalone and consolidated) for the quarter ended June 30, 2026, along with the Limited Review Report from statutory auditors. The board also approved the re-appointment of Mrs. Anjana Dikshit as an Independent Director for a second five-year term, effective November 10, 2026, subject to shareholder approval. Mrs. Dikshit is an IT professional with extensive experience and is not related to any existing directors or promoters. The financial results were reviewed by the Audit Committee.

Health X Platform Ltd announced its unaudited financial results for the quarter ended June 30, 2026. The Board of Directors approved and took on record the standalone and consolidated financial results, which were reviewed by the Audit Committee. The company also announced the re-appointment of Mrs. Anjana Dikshit as an Independent Director for a second term of five years, effective November 10, 2026, subject to shareholder approval. Mrs. Dikshit is an IT professional with extensive experience in global ERP implementations and currently serves on the boards of multiple public limited companies.